All In MedTech

FDA Clearance Tracker · P090022-S012

SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS (PCIOL)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 29, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 29, 2013

Approved

Time to decision

284 days

Received Apr 20, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P090022-S012
Device name
SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS (PCIOL)
Applicant
Lenstec, Inc.
Applicant location
St. Petersburg, FL
Received
Apr 20, 2012
Decided
Jan 29, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P090022

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE PRELOADED INJECTOR (PLI) INTRAOCULAR LENS (IOL) DELIVERY SYSTEM.

Source documents

Other decisions for Lenstec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.